Anthony Santiago, MD
About Anthony Santiago, MD
Chief Medical Officer
Dr. Santiago is a nationally-recognized clinical expert in neurodegenerative disorders, and highly-regarded investigator for both publicly-funded and sponsored research. He is the author of numerous peer‐reviewed journal articles and book chapters; frequent lecturer for patient advocacy groups, academic institutions, professional medical societies and biotechnology industry partners in pharmacological and medical-device development. In addition, he is passionate about medical education and is an award-winning educator, recognized for his outstanding didactic and clinical teaching while faculty at numerous medical schools.
Dr. Santiago is first and foremost a clinician, who emphasizes a holistic and humanistic approach to patient care, partnering with his patients and their families to create a relationship that is mutual and nurturing, while also championing clinical accuracy and scientific rigor.
He most recently served as the Chief Medical Officer and Director of the Parkinson’s Foundation National Center of Excellence at the Parkinson’s Institute and Clinical Center in California, an internationally-regarded leader in clinical care and investigative initiatives for neurodegenerative disorders; as the CMO and principal investigator, Dr. Santiago was responsible for the entire portfolio of clinical care delivery and clinical research efforts, as well as led all training programs associated with the Institute.
Prior to the Parkinson’s Institute and Clinical Center, Dr. Santiago served as the Chief Medical Officer and member of the Board of Directors for Pathways Group, Inc., a professional consortium of clinicians, data scientists, educators, academic and industry translational researchers, professional athletes and community leaders dedicated to improving the lives of people with neurodegenerative disorders. He was responsible for the development, validation and integration of medical content for its telehealth platform designed to solve the challenges inherent to providing a virtual portal for specialized patient care and clinical trial performance.
Prior to Pathways Group, Inc., Dr. Santiago was Vice-Chair of the Department of Neurology at the University of Minnesota (UMN) School of Medicine, where he also served as the Seiberlich Family Endowed Professor and Chief of the Divisions of Movement Disorders and Ataxia; Director of the Neurology Residency Program; Director of the Movement Disorders / Neuromodulation Fellowship Program; and Administrative Core Director for the Udall Parkinson’s Disease Center of Excellence.
Prior to his arrival at the UMN, he was Associate Professor of Neurology and National Parkinson Foundation Center Director at the Muhammad Ali Parkinson Center of the Barrow Neurological Institute – a designated National Center of Excellence in care delivery, education, research, and community outreach. He also served as the Director for Clinical and Translational Research in Movement Disorders / Neuromodulation Fellowship Program.
Dr. Santiago is an Alpha Omega Alpha graduate of the Albany Medical College in Albany, NY – where he also completed his post-graduate training in Neurology, a Fellowship in Movement Disorders / Neuromodulation, and upon finishing training, joined the faculty in the Neurology Department and continued his research in Neuropsychopharmacology and Deep Brain Stimulation. He is a Magna Cum Laude graduate of Le Moyne College, where he received his Bachelor of Science in Psychology and Chemistry.